highperformr logo

Adaptimmune's Overview

Total employees485
HeadquartersAbingdon
Founded2008

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company focused on the development of novel T-cell therapies for people with cancer. The company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy a wide range of cancer types, including solid tumors. Adaptimmune is advancing a pipeline of product candidates, with a focus on becoming a fully integrated cell therapy company.

Where is Adaptimmune's Headquarters?

Adaptimmune officeAdaptimmune officeAdaptimmune officeAdaptimmune office
*Images sourced via web search. Rights belong to original owners

HQ Function

The UK headquarters serves as the central hub for global corporate leadership, core research and development activities, and strategic operations for its T-cell therapy pipeline.

Notable Features:

Features state-of-the-art laboratory facilities, GMP-compliant manufacturing capabilities, and modern office spaces designed to foster collaboration and innovation among its scientific and operational teams.

Work Culture:

The work culture at Adaptimmune's headquarters is characterized by a strong emphasis on scientific excellence, innovation, collaboration, and a shared commitment to patients. Employees are driven by the mission to develop transformative cancer therapies.

HQ Significance:

This location is significant due to its proximity to world-class academic institutions and a thriving biotech ecosystem, facilitating talent acquisition and scientific partnerships. It underpins Adaptimmune's research engine and global strategy.

Values Reflected in HQ: The headquarters reflects Adaptimmune's core values of being patient-inspired, science-driven, and collaboratively-minded, evident in its cutting-edge infrastructure and focus on translational research.

Location:

Adaptimmune manages its global clinical trials, research collaborations, and business operations primarily from its main hubs in the United Kingdom (Abingdon, Oxfordshire) and the United States (Philadelphia, Pennsylvania). These locations support international trial sites, engagement with regulatory bodies across various countries, and foster scientific partnerships worldwide to advance its innovative T-cell therapies for cancer patients globally.

Street Address:

60 Jubilee Avenue, Milton Park

City:

Abingdon

State/Province:

Oxfordshire

Country:

United Kingdom

Adaptimmune's Global Presence

Philadelphia, Pennsylvania, USA

Address: 351 Rouse Boulevard, Philadelphia, PA 19112, USA

To lead and support U.S. clinical trials, manage regulatory interactions with the FDA, scale up manufacturing capabilities, and prepare for potential product launches in the North American market.

Buying Intent Signals for Adaptimmune

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Adaptimmune

As of April 2025, Adaptimmune' leadership includes:

Adrian Rawcliffe - Chief Executive Officer
Gavin Wood - Chief Financial Officer
Joanna Brewer, Ph.D. - Chief Scientific Officer
Elliot Norry, M.D. - Chief Medical Officer
Cintia Piccina, Pharm.D. - Chief Commercial Officer
Mark Dudley, Ph.D. - Chief Technology Officer
Wayne Davies - Chief People Officer

Investors of Adaptimmune

Adaptimmune has been backed by several prominent investors over the years, including:

Matrix Capital Management Company, LP
New Enterprise Associates (NEA)
Baillie Gifford & Co.
BlackRock, Inc.
The Vanguard Group, Inc.
Redmile Group, LLC

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

Over the past 12 months, Adaptimmune has made several key leadership appointments, including a new Chief Commercial Officer and Chief Financial Officer, alongside internal promotions to Chief Scientific Officer and Chief Technology Officer. There were also notable departures including the former CFO and the retirement of a co-founder and Chief Business Officer.

Departures

Michael Garone, Michael Garone departed as Chief Financial Officer, succeeded by Gavin Wood.
Helen Tayton-Martin, Helen Tayton-Martin retired as Chief Business Officer and Co-Founder at the end of 2023.

New Appointments:

Cintia Piccina, Cintia Piccina appointed as new Chief Commercial Officer.
Gavin Wood, Gavin Wood appointed as new Chief Financial Officer.
Joanna Brewer, Joanna Brewer promoted to Chief Scientific Officer.
Mark Dudley, Mark Dudley promoted to Chief Technology Officer.

Technology (Tech Stack) used by Adaptimmune

Discover the tools Adaptimmune uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Adaptimmune Email Formats and Examples

Adaptimmune primarily utilizes the email format consisting of the employee's first name followed by a period, then their last name, all preceding '@adaptimmune.com'. A less common, but also observed, format is the first initial of the first name followed by the last name.

first.last@adaptimmune.com

Format

jane.doe@adaptimmune.com

Example

85%

Success rate

News and media

Adaptimmune Press Release (via GlobeNewswire)May 9, 2024

Adaptimmune Reports First-Quarter 2024 Financial Results and Business Update

Adaptimmune provided updates on its pipeline, including progress with afami-cel towards potential BLA submission for synovial sarcoma, and its MAGE-A4 franchise. The company also reported financial results for the first quarter of 2024 and outlined key upcoming milestones....more

Adaptimmune Press Release (via GlobeNewswire)March 7, 2024

Adaptimmune Reports Fourth Quarter and Full-Year 2023 Financial Results and Business Update

The company highlighted significant clinical progress, including positive data for afami-cel in synovial sarcoma and advancements in its MAGE-A4 and PRAME targeted programs. Financial results for the fourth quarter and full year 2023 were also reported....more

Adaptimmune Press Release (via GlobeNewswire)November 20, 2023

Adaptimmune Announces Key Leadership Appointments to Support Next Phase of Growth

Adaptimmune announced the appointment of Gavin Wood as Chief Financial Officer, and the promotions of Dr. Joanna Brewer to Chief Scientific Officer and Dr. Mark Dudley to Chief Technology Officer, all effective January 2, 2024, to strengthen its leadership team....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Adaptimmune, are just a search away.